Rohan Patankar, DO
Internal Medicine · Hockley, TXNPI 1699041608
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $642 of the $1,038 with a category attached, or 61.8%. Insightec,inc accounts for 61.8% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $742, 2.8 times the $266 reported in 2019.
Across 8 payments — averaging $129.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Insightec,inc$642
- Vifor Pharma, Inc.$122
- Johnson & Johnson$100
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$100
- Pacira Therapeutics, Inc.$33
- Merck$27
- plus $15 from 1 others
What the payments were for
- Travel & lodging$64262%
- Food & beverage$39638%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Insightec,inc | 1 | $642 |
| Vifor Pharma, Inc. | 1 | $122 |
| Johnson & Johnson | 1 | $100 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $100 |
| Pacira Therapeutics, Inc. | 1 | $33 |
| Merck | 2 | $27 |
| Tactile Systems Technology Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,038 in reported general payments places this provider in the 70th percentile of 7,675 internal medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 61 | $1,266 |
| Ofloxacin | 12 | $387 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 25 | $278 |
| Fluticasone Propionate | 26 | $199 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 21 | $186 |
| Atorvastatin Calcium | 14 | $156 |
| Tramadol Hcl | 30 | $77 |
| Amoxicillin | 24 | $61 |
| Azithromycin | 14 | $27 |
| Meloxicam | 11 | $10 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Hockley
- Spencer BerthelsenSugar Land$891K
- Hameed AliTemple$773K
- Marc TribbleDallas$693K
- Gary SinclairDallas$599K
- Mohammed Al-NajjarEl Paso$586K
- Han SchmidlyDallas$465K
- Hussein TawbiHouston$365K
- Hans LeeHouston$327K
- Tapan KadiaHouston$311K
- Nitin JainHouston$281K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.